112 related articles for article (PubMed ID: 26011105)
1. Cancer of unknown primary is associated with diabetes.
Hemminki K; Försti A; Sundquist K; Li X
Eur J Cancer Prev; 2016 May; 25(3):246-51. PubMed ID: 26011105
[TBL] [Abstract][Full Text] [Related]
2. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
Bevier M; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
[TBL] [Abstract][Full Text] [Related]
4. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
6. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
[TBL] [Abstract][Full Text] [Related]
7. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
8. Risk of cancer of unknown primary among immigrants to Sweden.
Shu X; Sundquist K; Sundquist J; Hemminki K
Eur J Cancer Prev; 2012 Jan; 21(1):10-4. PubMed ID: 22044851
[TBL] [Abstract][Full Text] [Related]
9. Risk of cancer of unknown primary after hospitalization for autoimmune diseases.
Hemminki K; Sundquist K; Sundquist J; Ji J
Int J Cancer; 2015 Dec; 137(12):2885-95. PubMed ID: 26103152
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancer following hospitalization for type 2 diabetes.
Hemminki K; Li X; Sundquist J; Sundquist K
Oncologist; 2010; 15(6):548-55. PubMed ID: 20479278
[TBL] [Abstract][Full Text] [Related]
11. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
[TBL] [Abstract][Full Text] [Related]
12. Time trends in survival from cancer of unknown primary: small steps forward.
Riihimäki M; Hemminki A; Sundquist K; Hemminki K
Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
[TBL] [Abstract][Full Text] [Related]
13. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
Brustugun OT; Helland Å
Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
[TBL] [Abstract][Full Text] [Related]
14. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
[TBL] [Abstract][Full Text] [Related]
15. Association between anorexia nervosa and type 2 diabetes in Sweden: Etiological clue for the primary prevention of type 2 diabetes.
Ji J; Sundquist J; Sundquist K
Endocr Res; 2016 Nov; 41(4):310-316. PubMed ID: 26906648
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).
Afghahi H; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S; Hadimeri H; Svensson MK
Nephrol Dial Transplant; 2011 Apr; 26(4):1236-43. PubMed ID: 20817668
[TBL] [Abstract][Full Text] [Related]
17. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
[TBL] [Abstract][Full Text] [Related]
18. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
[TBL] [Abstract][Full Text] [Related]
19. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of prostate cancer among patients with diabetes mellitus.
Weiderpass E; Ye W; Vainio H; Kaaks R; Adami HO
Int J Cancer; 2002 Nov; 102(3):258-61. PubMed ID: 12397646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
